L04A immunosuppressive drug inmunosupresor 免疫抑制药 免疫抑制藥 L3
Source: Wikidata · CC0 1.0 Fuente: Wikidata · CC0 1.0 来源:维基数据 · CC0 1.0 來源:維基數據 · CC0 1.0
ATC level L3 · Search this class · Consumer categories
Child classes
L04AASelective immunosuppressants Selective immunosuppressants 选择性免疫抑制剂 選擇性免疫抑制劑L04ABTumor necrosis factor alpha (TNF-α) inhibitors Tumor necrosis factor alpha (TNF-α) inhibitors 肿瘤坏死因子α(TNF-α)抑制剂 腫瘤壞死因子α(TNF-α)抑制劑L04ACInterleukin inhibitors Interleukin inhibitors 白细胞介素抑制剂 白血球介素抑制劑L04ADcalcineurin inhibitor calcineurin inhibitor 钙调磷酸酶抑制剂 鈣調磷酸酶抑制劑L04AESphingosine 1-phosphate (S1P) receptor modulators Sphingosine 1-phosphate (S1P) receptor modulators Sphingosine 1-phosphate (S1P) receptor modulators Sphingosine 1-phosphate (S1P) receptor modulatorsL04AFJanus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitorsL04AGMonoclonal antibodies Monoclonal antibodies Monoclonal antibodies Monoclonal antibodiesL04AHMammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitorsL04AJComplement inhibitors Complement inhibitors Complement inhibitors Complement inhibitorsL04AKDihydroorotate dehydrogenase (DHODH) inhibitors Dihydroorotate dehydrogenase (DHODH) inhibitors Dihydroorotate dehydrogenase (DHODH) inhibitors Dihydroorotate dehydrogenase (DHODH) inhibitorsL04ALNeonatal fragment crystallizable receptor (FcRn) inhibitors Neonatal fragment crystallizable receptor (FcRn) inhibitors Neonatal fragment crystallizable receptor (FcRn) inhibitors Neonatal fragment crystallizable receptor (FcRn) inhibitorsL04AXOther immunosuppressants Other immunosuppressants 其它免疫抑制剂 其它免疫抑制劑
Active ingredients in this class
139 active ingredients 139 principios activos 139 个活性成分 139 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Methotrexate
L04AX03active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Lenalidomide
L04AX04Salt form: Lenalidomide Hydrochloride Monohydrate
Lenalidomide Hydrochloride Monohydrateactive US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Tacrolimus
L04AD02Salt form: Tacrolimus Monohydrate
Tacrolimus Monohydrateactive US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Leflunomide
L04AK01active US GB CA AU SG · and 9 more y 9 más 另有 9 个 另有 9 個
active US GB CA AU SG CN ES TW EU FR · discontinued MX · unknown HK - Pomalidomide
L04AX06active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Azathioprine
L04AX01active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Tofacitinib
L04AA29L04AF01Salt form: Tofacitinib Citrate
Tofacitinib Citrateactive US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Pirfenidone
L04AX05active US GB CA AU SG · and 9 more y 9 más 另有 9 个 另有 9 個
active US GB CA AU SG CN ES TW EU FR · discontinued MX · unknown HK - Fingolimod
L04AA27L04AE01Salt form: Fingolimod Hydrochloride
Fingolimod Hydrochlorideactive US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Teriflunomide
L04AK02active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Sirolimus
L04AH01active US GB CA AU SG · and 9 more y 9 más 另有 9 个 另有 9 個
active US GB CA AU SG CN ES TW EU FR · discontinued MX · unknown HK - Golimumab
L04AB06active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Secukinumab
L04AC10active US GB CA AU SG · and 9 more y 9 más 另有 9 个 另有 9 個
active US GB CA AU SG CN ES TW EU FR · discontinued MX · unknown HK - Cladribine
L04AA40active US GB CA AU SG · and 9 more y 9 más 另有 9 个 另有 9 個
active US GB CA AU SG CN ES TW EU FR · discontinued MX · unknown HK - Baricitinib
L04AF02active US GB CA AU SG · and 9 more y 9 más 另有 9 个 另有 9 個
active US GB CA AU SG CN ES TW EU FR · discontinued MX · unknown HK - Belimumab
L04AG04active US GB CA SG CN · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA SG CN ES MX TW EU FR · unknown AU HK - Ofatumumab
L04AG12active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Ritlecitinib
L04AF08active US GB CA SG CN · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA SG CN ES MX TW EU FR · unknown AU HK - Mycophenolate Mofetil
L04AAactive US GB CA SG CN · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA SG CN MX TW EU FR · unknown AU HK - Adalimumab
L04AB04active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Ustekinumab
L04AC05active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Apremilast
L04AA32active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES TW EU FR · discontinued MX - Tocilizumab
L04AC07active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG ES TW EU FR · discontinued MX · unknown HK - Etanercept
L04AB01active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG ES TW EU FR · discontinued MX · unknown HK - Infliximab
L04AB02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Risankizumab
L04AC18active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG ES TW EU FR · discontinued MX · unknown HK - Guselkumab
L04AC16active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Abatacept
L04AA24active US GB CA AU CN · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU CN ES TW EU FR · unknown MX HK - Upadacitinib
L04AF03active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG ES TW EU FR · discontinued MX · unknown HK - Vedolizumab
L04AG05active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Natalizumab
L04AG03active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Eculizumab
L04AJ01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES TW EU FR · unknown HK - Ixekizumab
L04AC13active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG ES TW EU FR · discontinued MX · unknown HK - Siltuximab
L04AC11active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES TW EU FR · unknown HK - Tildrakizumab
L04AC17active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Basiliximab
L04AC02active US GB CA SG CN · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA SG CN TW EU FR · discontinued MX · unknown AU HK - Deucravacitinib
L04AF07active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Dimethyl
L04AX07Salt form: Dimethyl Fumarate
Dimethyl Fumarateactive US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES TW EU FR · unknown HK - Bimekizumab
L04AC21active US GB CA AU ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU ES MX TW EU FR · unknown HK - Siponimod
L04AE03active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Certolizumab Pegol
L04AB05active US GB CA AU ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU ES TW EU FR · unknown MX HK - Ravulizumab
L04AJ02active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES TW EU FR · unknown HK - Alemtuzumab
L04AG06active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Ocrelizumab
L04AG08active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX EU FR · unknown HK - Danicopan
L04AJ09active US GB CA SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG ES TW EU FR · unknown AU HK - Canakinumab
L04AC08active US GB CA ES TW · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA ES TW EU FR · unknown AU MX HK - Iptacopan
L04AJ08active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES TW EU FR · unknown HK - Satralizumab
L04AC19active US GB CA SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG ES TW EU FR · unknown AU HK - Thalidomide
L04AXactive US GB CA AU SG · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU SG CN TW EU FR - Spesolimab
L04AC22active US GB CA SG TW · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG TW EU FR · unknown AU HK - Rozanolixizumab
L04AL02active US GB CA AU ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU ES TW EU FR · unknown HK - Anifrolumab
L04AG11active US CA AU ES MX · and 5 more y 5 más 另有 5 个 另有 5 個
active US CA AU ES MX TW EU FR · unknown HK - Etrasimod
L04AE05active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES EU FR · unknown HK - Avacopan
L04AJ05active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG CN FR · withdrawn ES EU - Teprotumumab
L04AG13active US GB CA SG TW · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG TW EU · discontinued ES · unknown AU HK - Mirikizumab
L04AC24active US GB CA ES MX · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES MX TW EU · unknown AU - Zilucoplan
L04AJ06active US GB CA AU ES · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU ES TW EU FR - Ozanimod
L04AA38L04AE02Salt form: Ozanimod Hydrochloride
Ozanimod Hydrochlorideactive US GB CA AU ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU ES TW EU · unknown HK - Efgartigimod Alfa
L04AL01active US GB CA SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG ES EU FR · unknown AU - Belumosudil
L04AA48active US GB CA TW EU · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA TW EU · discontinued ES · unknown AU HK - Remibrutinib
L04AA60active US GB CA TW EU · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA TW EU · discontinued ES · unknown AU HK - Brodalumab
L04AC12active US GB CA ES TW · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES TW EU FR · unknown HK - Mycophenolate
L04AAL04AA06Salt form: Mycophenolate Sodium
Mycophenolate Sodiumactive US AU SG CN ES · and 2 more y 2 más 另有 2 个 另有 2 個
active US AU SG CN ES TW FR - Mycophenolic Acid
L04AA06active US GB CA ES MX · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA ES MX · unknown AU HK - Sarilumab
L04AC14active US GB CA ES EU · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA ES EU FR · unknown HK - Pegcetacoplan
L04AJ03active US GB CA AU ES · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA AU ES EU FR - Anakinra
L04AC03active US GB CA AU ES · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA AU ES EU FR - Diroximel
L04AX09Salt form: Diroximel Fumarate
Diroximel Fumarateactive US GB AU ES MX · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB AU ES MX EU FR - Belatacept
L04AA28active US GB ES EU FR · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB ES EU FR · unknown AU MX - Inebilizumab
L04AG10active US CA ES TW EU · and 3 more y 3 más 另有 3 个 另有 3 個
active US CA ES TW EU FR · unknown AU - Ciclosporin
L04ADactive SG CN TW EU FR · and 2 more y 2 más 另有 2 个 另有 2 個
active SG CN TW EU FR · unknown AU - Ponesimod
L04AE04active US GB CA ES EU · and 1 more y 1 más 另有 1 个 另有 1 個
active US GB CA ES EU FR - Filgotinib
L04AF04active GB SG ES TW EU · and 1 more y 1 más 另有 1 个 另有 1 個
active GB SG ES TW EU FR - Nerandomilast
L04AA61active US GB CA TW EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA TW EU · discontinued ES - Crovalimab
L04AJ07active US GB CA ES TW · and 1 more y 1 más 另有 1 个 另有 1 個
active US GB CA ES TW EU - Nipocalimab
L04AL03active US GB CA EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA EU · discontinued ES - Ublituximab
L04AG14active US GB AU ES EU
active US GB AU ES EU - Imlifidase
L04AA41active GB EU FR · and 2 more y 2 más 另有 2 个 另有 2 個
active GB EU FR · unknown AU - Voclosporin
L04AD03active US GB ES EU
active US GB ES EU - Darvadstrocel
L04AX08active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · withdrawn ES EU FR
Show all 139 (currently showing 80) Mostrar los 139 (ahora se muestran 80) 显示全部 139 个(当前显示前 80 个) 顯示全部 139 個(目前顯示前 80 個)
- Efalizumab
L04AG02active GB · and 6 more y 6 más 另有 6 个 另有 6 個
active GB · discontinued CA · withdrawn EU · unknown MX - Sutimlimab
L04AJ04active US ES EU FR
active US ES EU FR - Alefacept
L04AA15active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · discontinued CA · unknown MX - Daclizumab
L04AC01active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · discontinued CA · withdrawn EU - Tolebrutinib
L04AA62active EU · and 4 more y 4 más 另有 4 个 另有 4 個
active EU · discontinued ES · unknown AU - 抗人T细胞兔免疫球蛋白
L04AASalt form: 抗人T细胞猪免疫球蛋白
抗人T细胞猪免疫球蛋白active CN FR
active CN FR - Emapalumab
L04AA39active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · unknown EU - Talidomida
L04AX02active ES · and 2 more y 2 más 另有 2 个 另有 2 個
active ES · discontinued MX - Daclizumab Beta
L04AC01discontinued CA · and 2 more y 2 más 另有 2 个 另有 2 個
discontinued CA · withdrawn EU - Muromonab-Cd3
L04AG01active GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · discontinued CA - Rilonacept
L04AC04active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · withdrawn EU - Vilobelimab
L04AJ10active US EU
active US EU - 阿达木单抗
L04ABactive CN
active CN - 咪唑立宾
L04AXactive CN
active CN - 托珠单抗
L04ACactive CN
active CN - 人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白
L04ABactive CN
active CN - 富马酸二甲酯
L04AXactive CN
active CN - 依那西普
L04ABactive CN
active CN - 乌帕替尼
L04AAactive CN
active CN - 佩索利单抗
L04ACactive CN
active CN - 英夫利西单抗
L04ABactive CN
active CN - 罗普司亭N01
L04AGSalt form: 替妥尤单抗N01
替妥尤单抗N01active CN
active CN - 乌司奴单抗
L04ACactive CN
active CN - 古塞奇尤单抗
L04ACactive CN
active CN - 西尼莫德
L04AAactive CN
active CN - Espesolimab
L04AC22active ES
active ES - 泰它西普
L04AAactive CN
active CN - 氘可来昔替尼
L04AAactive CN
active CN - 盐酸伊普可泮
L04AJactive CN
active CN - 伊奈利珠单抗
L04AAactive CN
active CN - 依马利尤单抗
L04AAactive CN
active CN - 培塞利珠单抗
L04ABactive CN
active CN - 阿那白滞素
L04ACactive CN
active CN - 兔抗人胸腺细胞免疫球蛋白
L04AAactive CN
active CN - 盐酸奥扎莫德
L04AAactive CN
active CN - 抗CD25人源化单克隆抗体
L04ACactive CN
active CN - 艾加莫德α
L04AAactive CN
active CN - Prodiginine
L04AXactive CN
active CN - Antithymocyte Immunoglobulin (Rabbit)
L04AA04active GB
active GB - Basilixmab
L04AC02active ES
active ES - Fumarato De Tegomil
L04AX10discontinued ES
discontinued ES - Inmunoglobulina Antitimocítica De Conejo
L04AA04active ES
active ES - Lymphocyte Immunoglobulin Anti-Thymocyte Globulin
L04AA03active CA
active CA - 依奇珠单抗
L04ACactive CN
active CN - 替瑞奇珠单抗
L04ACactive CN
active CN - 赛立奇单抗
L04ACactive CN
active CN - 比奇珠单抗
L04ACactive CN
active CN - 维得利珠单抗
L04AAactive CN
active CN - 布罗利尤单抗
L04ACactive CN
active CN - 甲磺酸贝舒地尔
L04AAactive CN
active CN - 夫那奇珠单抗
L04ACactive CN
active CN - 萨特利珠单抗
L04ACactive CN
active CN - 利纳西普
L04ACactive CN
active CN - Anti-Thymocyte Globulin
L04AA04active CA
active CA - Icotrokinra Containing Product
L04AC28discontinued ES
discontinued ES - Imlifidasa
L04AA41active ES
active ES - Pozelimab
L04AJ11active US
active US - Remestemcel-L
L04AXactive CA
active CA - Ritlecitinib Tosylate
L04AF08
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.